Analyst Consensus ?
ConsensusHold29 ratings
Bullish1551.7%
Neutral1344.8%
Bearish13.5%
FN2 Earnings Intelligence
Tyson Foods, Inc. (TSN) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Oct 7, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Sep 18, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 4, 2026 |
| Barclays | Overweight | Overweight | Maintain | Sep 4, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jul 2, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 2, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| Mizuho | Outperform | Buy | Maintain | Mar 26, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| HSBC | Reduce | Reduce | Maintain | May 7, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 17, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 7, 2023 |
| Argus Research | Hold | Buy | Downgrade | Sep 13, 2022 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 13, 2019 |
| Argus | Buy | Hold | Upgrade | May 14, 2019 |
| Vertical Research | Buy | Hold | Upgrade | Jan 10, 2019 |
| Vertical Group | Buy | Hold | Upgrade | Jan 10, 2019 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 8, 2018 |
| Pivotal Research | Hold | Sell | Upgrade | Nov 13, 2017 |
| Jefferies | Buy | Buy | Maintain | Oct 30, 2017 |
| CLSA | Buy | Outperform | Maintain | Oct 10, 2016 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 4, 2016 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jan 5, 2016 |
| Cleveland Research | Buy | Neutral | Upgrade | Feb 5, 2015 |
| Keybanc | Buy | Buy | Maintain | Jul 29, 2014 |
| DA Davidson | Buy | Buy | Maintain | Jul 10, 2013 |
| Miller Tabak | Buy | Neutral | Upgrade | May 7, 2013 |
Upside is calculated against the persisted previous close $55.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $56 | $51.97 | +1.2% | Oct 7, 2026 |
| Piper Sandler | Analyst unavailable | $66 | $51.74 | +19.2% | Sep 10, 2026 |
| Barclays | Analyst unavailable | $75 | $51.76 | +35.5% | Sep 4, 2026 |
| BMO Capital | Andrew Strelzik | $65 | $51.76 | +17.4% | Sep 4, 2026 |
| Bernstein | Alexia Howard | $66 | $58.12 | +19.2% | Aug 4, 2026 |
| Coker Palmer | Thomas Palmer | $65 | $57.48 | +17.4% | Jul 14, 2026 |
| Bernstein | Analyst unavailable | $63 | $58.43 | +13.8% | Jul 2, 2026 |
| Piper Sandler | Michael Lavery | $78 | $56.2 | +40.9% | Jun 18, 2026 |
| Piper Sandler | Analyst unavailable | $80 | $68.76 | +44.5% | May 4, 2026 |
| Bernstein | Analyst unavailable | $69 | $65.74 | +24.6% | Feb 3, 2026 |
| BMO Capital | Andrew Strelzik | $73 | $65.74 | +31.9% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $78 | $65.74 | +40.9% | Feb 3, 2026 |
| BMO Capital | Analyst unavailable | $67 | $56.2 | +21.0% | Jan 8, 2026 |
| Piper Sandler | Michael Lavery | $61 | $59.56 | +10.2% | Dec 12, 2025 |
| Stephens | Pooran Sharma | $61 | $55.75 | +10.2% | May 6, 2025 |
| Coker Palmer | Thomas Palmer | $60 | $60.54 | +8.4% | Apr 15, 2025 |
| Piper Sandler | Michael Lavery | $58 | $61.69 | +4.8% | Nov 13, 2024 |
| BMO Capital | Andrew Strelzik | $62 | $61.69 | +12.0% | Nov 13, 2024 |
| Barclays | Benjamin Theuer | $76 | $62.66 | +37.3% | Nov 12, 2024 |
| Bank of America Securities | Peter Galbo | $62 | $59.85 | +12.0% | Oct 15, 2024 |
| Piper Sandler | Michael Lavery | $50 | $60.52 | -9.7% | Sep 25, 2024 |
| Barclays | Benjamin Theuer | $72 | $65.13 | +30.1% | Sep 5, 2024 |
| BMO Capital | Andrew Strelzik | $60 | $62.08 | +8.4% | Aug 6, 2024 |
| Coker Palmer | Thomas Palmer | $63 | $62.51 | +13.8% | Aug 5, 2024 |
| Piper Sandler | Michael Lavery | $57 | $58.33 | +3.0% | May 7, 2024 |
| BMO Capital | Andrew Strelzik | $58 | $58.28 | +4.8% | May 7, 2024 |
| Barclays | Benjamin Theuer | $69 | $58.12 | +24.6% | Apr 16, 2024 |
| Coker Palmer | Thomas Palmer | $62 | $57.6 | +12.0% | Apr 3, 2024 |
| Loop Capital Markets | Andrew Strelzik | $46 | $47.77 | -16.9% | Nov 14, 2023 |
| Stephens | Ben Bienvenu | $70 | $47.58 | +26.4% | Nov 14, 2023 |
| Barclays | Benjamin Theurer | $50 | $46.39 | -9.7% | Nov 10, 2023 |
| UBS | Kevin Caliendo | $37 | $52.66 | -33.2% | Jul 24, 2023 |
| Deutsche Bank | Steve Powers | $35 | $50.39 | -36.8% | May 19, 2023 |
| Bernstein | Alexia Howard | $48 | $48.95 | -13.3% | May 9, 2023 |
| J.P. Morgan | Analyst unavailable | $63 | $59.92 | +13.8% | Feb 7, 2023 |
| Credit Suisse | Analyst unavailable | $58 | $61.08 | +4.8% | Feb 7, 2023 |
| Goldman Sachs | Analyst unavailable | $66 | $61.08 | +19.2% | Feb 7, 2023 |
| Piper Sandler | Analyst unavailable | $65 | $65.75 | +17.4% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $58 | $67.33 | +4.8% | Nov 28, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $64.34 | +26.4% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $75 | $64.83 | +35.5% | Nov 15, 2022 |
| Piper Sandler | Michael Lavery | $79 | $79.92 | +42.7% | Aug 9, 2022 |
| Piper Sandler | Michael Lavery | $85 | $92.84 | +53.5% | May 10, 2022 |
| Piper Sandler | Michael Lavery | $81 | $90.1 | +46.3% | May 3, 2022 |
| BMO Capital | Kenneth Zaslow | $99 | $87.14 | +78.8% | Mar 18, 2022 |
Track every rating change on TSN the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.